A Phase I/II, open-label, multicentre, dose escalation study assessing the safety and tolerability of pEYS606 when administered by electrotransfer (ET) in the ciliary muscle of patients with non infectious posterior, intermediate or panuveitis.
Research Grant
Administered By
Ophthalmology
Awarded By
Eyevensys
Start Date
October 6, 2017
End Date
June 30, 2022
Administered By
Ophthalmology
Awarded By
Eyevensys
Start Date
October 6, 2017
End Date
June 30, 2022